Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of oxycodone and mebeverin mixed effects on colonoscopy quality
IRCT20201204049599N3Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of oxycodone and mebeverine in None, sponsored by Urmia University of Medical Sciences. Started Apr 2021; status: completed.
02
Drugs
oxycodonemebeverine
Beyond the preview
Go deeper on IRCT20201204049599N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201204049599N3.